chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vial of Moderna with a BUD of 6/16/22 based on removal from freezer on 5/17/22, vial was given at approximately 8:30 am; dose administered after 30 day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered after 30 day use by date) and PRODUCT STORAGE ERROR (vial of Moderna with a BUD of 6/16/22 based on removal from freezer on 5/17/22, vial was given at approximately 8:30 am) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 17-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered after 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial of Moderna with a BUD of 6/16/22 based on removal from freezer on 5/17/22, vial was given at approximately 8:30 am). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose administered after 30 day use by date) and PRODUCT STORAGE ERROR (vial of Moderna with a BUD of 6/16/22 based on removal from freezer on 5/17/22, vial was given at approximately 8:30 am) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug was reported. It was reported that Moderna vial had a before use date of 16-Jun-2022 based on removal from freezer on 17-May-2022.  A booster dose from that vial was given at approximately 8:30 am. No treatment drug was reported.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022; No adverse event; The patient administered the vaccine after the 30 days by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022).    No concomitant medications was provided by the reporter. Patient received half dose. The vial had not undergone any temperature excursions. The vial was initially stored in the refrigerator on 04-jun-2022. No treatment medications was provided by the reporter.
Day 1: The evening of shot, my entire body began to feel achy, and my arm was so sore that I couldn?t sleep.  Day 2:  body very achy. Theraflu helped with aches. Lymph node under arm swelled up to the size of a 1/2 grapefruit and was so painful that I took hydrocodone for one day to deal with it. It was throbbing and occasionally shooting pain around armpit area. I couldn?t let my arm touch it. I was a bit sweaty and hot and slept most of the day.   Day 3: I noticed small bruises under my armpit. The area was still very sore but bearable. I couldn?t use that arm at all. I also got a rash in my back  on the right side that was extremely itchy for a minute and then was just red. It faded somewhat quickly. I called my dr because I was concerned about reactions. He told me to come in Monday for blood tests because my reactions were concerning. Later that night when I got undressed for bed, I saw that I now had 7 bruises all on my right side all around armpit area. Tired.   Day 4: feeling pretty normal. Arm is still very sore, but I can use it. I can?t lift my arm without discomfort. Only new bruise is a BIG one on my arm. I finally figured out it was from taking off my shirt!  Day 5 etc = feeling better and better except for occasional vertigo in morning and dizziness throughout the day.
On 7th day after receiving Moderna vaccine, spontaneously developed 3" Discrete wheal surrounding injection site consistent with injection site reaction.
MRI showed a large, fast-growing cancer in her abdomen; intense lower back pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 71-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NEOPLASM MALIGNANT (death, medically significant), outcome "fatal", described as "MRI showed a large, fast-growing cancer in her abdomen"; BACK PAIN (non-serious), outcome "unknown", described as "intense lower back pain". The events "mri showed a large, fast-growing cancer in her abdomen" and "intense lower back pain" required emergency room visit. The patient underwent the following laboratory tests and procedures: Magnetic resonance imaging: fast-growing cancer in her abdomen. The patient date of death was unknown. Reported cause of death: "MRI showed a large, fast-growing cancer in her abdomen". It was not reported if an autopsy was performed.  Clinical course: Patient was in good health. No family history of cancer. Her husband had been diagnosed with Alzheimer. VAERS report indicates the baby my vaccinated daughter is carrying is a hundred fold more likely to have birth defects.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: MRI showed a large, fast-growing cancer in her abdomen
This spontaneous report as received from an immunization official (also reported as health care worker) refers 7 patients (demographics unspecified). Between 01-NOV-2012 to 15-NOV-2012, the patients might have received VARIVAX (Merck) (lot number, expiry date, dose, route, site unspecified) that were exposed to unknown temperatures. The VARIVAX (Merck) were exposed to unknown temperatures from 01-NOV-2012 to 15-NOV-2012. Immunization official reported that the practice had no vaccine temperature storage records for the time period in question; it could not be determined if a vaccine temperature storage excursion actually occurred. No adverse effect reported. The outcome was unknown. It was unspecified if the patients had sought medical attention. All telephone attempts to obtain follow-up information has been unsuccessful. This is one of several reports from the same source. Additional information has been requested.
pt got vaccine in AM of 4/1/21- she said she then went to sleep a few hours later and slept x 18 hours. when she awoke the next day she had left arm and left leg weakness. she was seen in provider office and her weakness was noted- shse was sent for stat non-contrast CT of brain which was negative for acute ischemic event. Her neurologist was informed, the pt was stasrted on daily baby aspirin and she is scheduled for an MRA/MRI of brain/neck and f/u appt w/neurology
pt recv vax 1996 & 26JUN97 lab eval revealed titers of 0.21;
Patient came in on 3-21-19 to report that in AM she broke with rash all over her neck. She was trying to find out if that is normal reaction to vacc. she received. She was advised to take BENADRYL and watch it. In case the condition was getting worse she was advised to go to the Urgent Care or ER.
2 days, post vax, injection site swelled to 3" in diameter, was warm to touch and sore. He couldn't lift arm above head. No swelling on 7/9 but arm feels tight. Then on 7/12 at 03:00, he woke up with swollen elbow, red and warm to touch. Seen by MD and dx'd with acute bursitis. Treated with antibiotic therapy.
Bedtime chills and body aches on 9/24/2022 Fainting occured about 6:30 AM  on 9/25/2022 and resulted in admittance to emergency dept of local hospital.  Laceration of scalp from the fall that occured when patient fainted. Whiplash was also indicated.
On  unspecified dates, the pt received 3 injections of Lymerix. The physician reported that he had a negative titer after receiving the 3 injections. The most recent information received on 5/18/2000, reports the outcome of the event as unknown.
Information has been received from a mother concerning her son with no allergies or past medical history who was vaccinated SC with a 0.5ml dose of MMR. There was no concomitant medication. Two or three days after the vaccination the patient got a fever, then he had seizure and was brought to the pediatric office and no laboratory testing done. The patient's mother does not remember exactly when he go the vaccination. The mother felt that the patient's experiences were disabling at that time. It was reported that the patient recovered. Additional information has been requested.
Lymph node swell on left side in chest, 2 weeks, No treatment and is currently recovered.
Area of her tongue taste weird; Food taste weird; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Mar-2021. The most recent information was received on 03-May-2021 and was forwarded to Moderna on 03-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DISORDER (Area of her tongue taste weird) and TASTE DISORDER (Food taste weird) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010m20a) for COVID-19 immunisation.     The patient's medical history was not provided.  Concomitant products included LISINOPRIL, VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE XR), ATORVASTATIN CALCIUM (LIPITOR) and CELECOXIB.    On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced TONGUE DISORDER (Area of her tongue taste weird) and TASTE DISORDER (Food taste weird). At the time of the report, TONGUE DISORDER (Area of her tongue taste weird) and TASTE DISORDER (Food taste weird) was resolving.            Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: AE outcome
Morning after vaccine: chills, fever, muscle aches, pain around injection site. The next day, I was fine with moderate pain at injection site I did not experience these symptoms with the first injection.
On 1/5/11, AM RN gave influenza, Hepatitis A and HPV vaccines. She also received PPD on L arm. Pt stood up after receiving last vaccine (HPV) felt dizzy and fell. RN heard noise and found her on the floor. Pt was noticed to have slight movement & was alert, responding to commands HR 48, B/P 96/60. Pt was unconscious briefly, awoke quickly. Not confused afterwards. Pt reports blacking out after phlebotomy in the past. She was examined by PCP. EK done - sinus bradycardia. Discharged home in stable condition. Pt was advised to alert future vaccine administrators or phlebotomists to her history of syncopal episode.
Information has been received from a physician's assistant concerning a male patient who was vaccinated with a dose of varicella virus vaccine live. In approximately February 2006 the patient's unvaccinated sister developed chickenpox. Subsequently, the patient developed a small breakthrough case. Unspecified medical attention was sought. The patient's outcome was not reported. The patient's brother (WAES0603USA02700) also developed a case of breakthrough. Additional information has been requested.
body aches; headache; skin sensitivity; swelling; This is a spontaneous report from a contactable consumer (Patient) reported that:  A 28-years-old female patient (non-pregnant) received bnt162b2 (PFIZER BIONTECH COVID-19 Vaccine, Solution for injection, Batch/Lot Number: ER8732) via an unspecified route of administration, administered in Arm Left on 27Apr2021 14:15 (Age at vaccination 28-years-old) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history included obesity. The patient was allergies to amoxicillin and penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included aleve and excedrin extra strength. The patient received other medications within 2 weeks of vaccination. Patient previously received bnt162b2 (PFIZER BIONTECH COVID-19 Vaccine, Solution for injection, Batch/Lot Number: ER8733) via an unspecified route of administration, administered in Arm Left on 06Apr2021 14:15 (Age at vaccination-28-years-old) as DOSE 1, SINGLE for COVID-19 immunization. On 27Apr2021 05:00PM, the patient had experienced body aches, headache, skin sensitivity and swelling. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The patient has not recovered from the events.  No follow-up attempts are possible. No further information is expected.
Took first Covid vaccine 03/17/2021. Developed double pneumonia. Took 2nd Covid vaccine 06/10/2021. 6/11/202, had fever of 100 degrees. Over the next few days, fever increased. Also was fatigued. Family couldn't speak to her in Rehab center. Requested that she go to the hospital. Request denied. Passed away 06/14/2021 due to heart failure.
Information has been received on 24-AUG-2017 from a nurse regarding an unspecified number of patients of unknown ages and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On 22-AUG-2017 and 24-AUG-2017 doses of improperly stored VAQTA lot # N016805, expiration 04-SEP-2018 intramuscular were administered to unspecified patients for prophylaxis. No adverse effects were reported. The vaccines were stored at the temperature of 20 degrees Fahrenheit for the time frame of 24 hours. There was no previous temperature excursion. The call was not made due to a data logger. This is one of two reports received from the same reporter. Additional information has been requested.
I have a little bit of a rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (I have a little bit of a rash) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Ragweed allergy and Bee sting.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced RASH (I have a little bit of a rash). At the time of the report, RASH (I have a little bit of a rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 01-MAY-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength and route were unknown) (lot# N020352 and expiration date 10-APR-2020) for prophylaxis (Incorrect product storage). No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018   was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001957: US-009507513-1810USA001958: US-009507513-1810USA001959: US-009507513-1809USA003709:
Woke up mid-morning on Friday, July 9th, to dizziness (vertigo) when I sat up but it quickly went away after a few seconds. Saturday morning, July 10th, after 10 AM I woke up and had brief vertigo after I rolled over. It went away after a few seconds to a minute, then I sat up. Went to use the bathroom when it struck again while I was sitting on the toilet. I had to lean against the wall for a few seconds before it went away. Finished up, then went back to bed and took a nap. Woke up around 11:50-something but continued to rest/doze until 2:30-something PM. Got up and ate but felt tired afterwards. As I'm writing this at 9:10 PM I'm still feeling tired.
Expired dose administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 69-year-old male patient who received HBV (Engerix B) (batch number 9P9B5, expiry date 7th February 2022) for prophylaxis.   On 16th February 2022, the patient received Engerix B. On 16th February 2022, unknown after receiving Engerix B, the patient experienced expired vaccine used. On 16th February 2022, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The patient received an expired dose of Engerix-B, which led to expired vaccine used. The reporter consented to follow up.
Pt received the vaccine on 10/25/2017, returned to the clinic on 10/27/17 for nausea and pain at the injection site with redness, tenderness and swelling at the site. Much tenderness to touch reported.
Symptoms started as very painful second toe of left foot with the ball of the left foot also very sensitive. After a day or two the pain changed and spread to the balls of both feet.  After a week the balls of the feet are not so sensitive, but the tops of the forefoot were painful with some swelling, especially in the left foot. At this time (two weeks after receiving the Moderna booster shot) the tops of the feet are very tender making it painful to walk.
Patient returned to clinic with reports of redness and swelling at the site of injection, but also complained that she woke up with the swollen nodes. On exam, patient was noted to have very swollen and tender supraclavicular lymph nodes. Advised patient to treat symptomatically with cool compresses and ibuprofen and to follow-up with primary care physician for worsening symptoms or persistent swollen nodes.
Patient reported dizziness and nausea following the administration of vaccine. Patient reported dizziness, lightheadedness, nausea, and exhibited hypertension throughout monitoring period. Patient monitored for a total of 1hr and 30 minutes. Patient received apple juice, water, and crackers during monitoring  period. Patient remained alert and oriented during monitoring period. Patient reported feelings of anxiety prior to vaccination. Patient exhibited various blood pressure reading see the following, 121/80 HR 79, 130/87 HR 79, 129/81 HR 82, 140/86 HR 79, 150/86 HR 77, 136/86 HR 76, 170/102 HR 86. Patient final blood pressure reading prior to leaving the facility was 175/102 HR 82.  Patient requested transfer to emergency room due to increased nausea, dizziness/ lightheadedness, and hypertension. Patient denied shortness of breath or difficulty breathing throughout monitoring period and prior to transfer.
Heart attack; Stroke; Blood clots; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYOCARDIAL INFARCTION (Heart attack), CEREBROVASCULAR ACCIDENT (Stroke) and THROMBOSIS (Blood clots) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYOCARDIAL INFARCTION (Heart attack) (seriousness criteria hospitalization and medically significant) and CEREBROVASCULAR ACCIDENT (Stroke) (seriousness criteria hospitalization and medically significant). an unknown date, the patient experienced THROMBOSIS (Blood clots) (seriousness criteria hospitalization and medically significant). The patient was treated with Surgery for Thrombosis. At the time of the report, MYOCARDIAL INFARCTION (Heart attack), CEREBROVASCULAR ACCIDENT (Stroke) and THROMBOSIS (Blood clots) outcome was unknown.            Concomitant product use was not provided.  It was reported that the patient experienced heart attack, stroke, and uncontrollable blood clotting after 5 days of vaccine. Patient was also admitted at hospital for surgery.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Previous two shots were Moderna, third booster was Pfizer. Mom experienced swollen bottom lip upon waking, tingling.